mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.33 |
2e-09 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
2e-09 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
8e-09 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-08 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-08 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-08 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
9e-08 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-07 |